The FDA has approved two new drugs for the treatment of hepatitis C the first new drugs to be approved in years.
Niacin may not be effective in preventing cardiovascular disease.
Osteoporosis is a highly prevalent metabolic bone disease that affects both men and woman at risk of bone demineralization.
With the advent of new vaccines, the incidence of bacterial meningitis has declined, particularly in children, but the mortality rate has remained the same.
Variant Creutzfeldt-Jakob disease usually presents with subtle psychiatric symptoms and there is usually a significant delay in diagnosis.
Patients originally on interferon beta-1a in the TRANSFORMS study were re-randomized to either 0.5 or 1.25 mg of fingolimod. There was a reduction in relapse rate and MRI activity in patients that switched to fingolimod without an increase in severe adverse events.
